Neurogene
NGNE
NGNE
80 hedge funds and large institutions have $119M invested in Neurogene in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 26 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 20
37% less capital invested
Capital invested by funds: $187M → $119M (-$68.3M)
Holders
80
Holding in Top 10
–
Calls
$1.28M
Puts
$180K
Top Buyers
| 1 | +$2.64M | |
| 2 | +$525K | |
| 3 | +$418K | |
| 4 |
JP Morgan Chase
New York
|
+$387K |
| 5 |
Two Sigma Advisers
New York
|
+$290K |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$1.33M | |
| 3 | -$906K | |
| 4 |
Swiss National Bank
Zurich,
Switzerland
|
-$534K |
| 5 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$435K |